NEW YORK (GenomeWeb) – Syapse and Intermountain Healthcare said today that they will collaborate to offer Intermountain's network of oncologists, tools for genomics-driven cancer care.

Intermountain is a non-profit system of 22 hospitals, 185 physician clinics, and an affiliated health insurance company. It selected Syape's software to provide oncologists with access to tumor genome profiling, data analysis, and drug procurement services.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: researchers classify pancreatic cancer into four subtypes using sequencing, and more.

Genotyping analysis of measles in Ontario indicates the strain there didn't originate from Disneyland or Europe.

The UK Medical Research Council says the proposed path of a new train line could affect research at the Francis Crick Institute.

The House of Lords in the UK approves a bill to allow mitochondrial donation.